Young Tae Park, MD | Authors

Articles

Oral UFT and Leucovorin in Patients With Advanced Gastric Carcinoma

September 02, 1997

Thirty-nine patients with locally advanced or metastatic gastric carcinoma received oral UFT (tegafur and uracil) plus leucovorin. Treatment consisted of UFT 360 mg/m2/day plus leucovorin 25 mg/m2/day, given orally in divided